Vanguard Group Inc. Grows Holdings in The Chemours Company $CC

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Vanguard Group Inc. grew its holdings in The Chemours Company (NYSE:CC - Free Report) by 8.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,487,008 shares of the specialty chemicals company's stock after purchasing an additional 1,263,047 shares during the period. Vanguard Group Inc. owned about 11.03% of Chemours worth $223,069,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. FNY Investment Advisers LLC purchased a new position in shares of Chemours during the first quarter valued at $27,000. UMB Bank n.a. increased its stake in shares of Chemours by 73.9% during the first quarter. UMB Bank n.a. now owns 2,231 shares of the specialty chemicals company's stock valued at $30,000 after buying an additional 948 shares during the period. Farther Finance Advisors LLC increased its stake in shares of Chemours by 170.7% during the first quarter. Farther Finance Advisors LLC now owns 2,290 shares of the specialty chemicals company's stock valued at $30,000 after buying an additional 1,444 shares during the period. Itau Unibanco Holding S.A. increased its stake in shares of Chemours by 39.3% during the fourth quarter. Itau Unibanco Holding S.A. now owns 3,554 shares of the specialty chemicals company's stock valued at $60,000 after buying an additional 1,003 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Chemours during the fourth quarter valued at $91,000. Hedge funds and other institutional investors own 76.26% of the company's stock.

Insider Buying and Selling at Chemours

In other Chemours news, CEO Denise Dignam purchased 4,068 shares of the stock in a transaction dated Friday, August 8th. The stock was acquired at an average cost of $12.06 per share, for a total transaction of $49,060.08. Following the acquisition, the chief executive officer owned 191,546 shares in the company, valued at $2,310,044.76. This trade represents a 2.17% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Damian Gumpel purchased 7,822 shares of the stock in a transaction dated Tuesday, June 3rd. The shares were acquired at an average price of $9.95 per share, with a total value of $77,828.90. Following the completion of the acquisition, the insider owned 131,701 shares in the company, valued at approximately $1,310,424.95. This trade represents a 6.31% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 25,290 shares of company stock valued at $250,437. 0.34% of the stock is owned by company insiders.

Chemours Trading Up 2.1%

Shares of CC stock opened at $14.92 on Tuesday. The company has a debt-to-equity ratio of 17.16, a current ratio of 1.68 and a quick ratio of 0.83. The company has a market cap of $2.23 billion, a price-to-earnings ratio of -5.33 and a beta of 1.61. The stock has a 50 day simple moving average of $12.64 and a 200-day simple moving average of $12.98. The Chemours Company has a 1-year low of $9.13 and a 1-year high of $22.38.

Chemours (NYSE:CC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.46 by $0.12. Chemours had a positive return on equity of 35.14% and a negative net margin of 7.19%. The firm had revenue of $1.62 billion during the quarter, compared to analysts' expectations of $1.57 billion. During the same period in the previous year, the business earned $0.38 earnings per share. The firm's revenue for the quarter was up 5.0% on a year-over-year basis. On average, equities research analysts expect that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 15th will be issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 2.3%. The ex-dividend date is Friday, August 15th. Chemours's dividend payout ratio is presently -12.50%.

Wall Street Analysts Forecast Growth

CC has been the topic of a number of recent research reports. Barclays dropped their price objective on Chemours from $16.00 to $13.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 28th. Morgan Stanley dropped their price objective on Chemours from $22.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Monday, May 12th. Royal Bank Of Canada raised their price objective on Chemours from $14.00 to $15.00 and gave the company an "outperform" rating in a research report on Thursday, July 3rd. Wall Street Zen downgraded Chemours from a "hold" rating to a "sell" rating in a research report on Wednesday, May 21st. Finally, Mizuho raised their price target on Chemours from $13.00 to $16.00 and gave the stock an "outperform" rating in a report on Tuesday, July 15th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $17.38.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.